Corza Medical Inc. entered into an agreement to acquire TachoSil manufacturing operations in Linz, Austria. from Takeda Pharmaceutical Company Limited (TSE:4502) on April 26, 2023. The transaction is subject to the satisfaction of certain anti-trust and FDI customary regulatory approvals. The transaction is expected to close by the first quarter of 2024.

Corza Medical Inc. completed the acquisition of TachoSil manufacturing operations in Linz, Austria. from Takeda Pharmaceutical Company Limited (TSE:4502) on July 1, 2024.